O
30
-3
RCL
69
3
SIG
44
4
DE
53
-2
FMC
46
9
FITB
66
-2
CFG
75
8
SYF
76
2
HON
72
2
CTAS
53
8
QCOM
55
-2
EBAY
54
7
NFLX
57
4
EXPD
29
2
MNST
44
2
ETN
80
2
KEY
68
3
ICE
53
4
AN
43
-6
ROST
55
3
O
30
-3
RCL
69
3
SIG
44
4
DE
53
-2
FMC
46
9
FITB
66
-2
CFG
75
8
SYF
76
2
HON
72
2
CTAS
53
8
QCOM
55
-2
EBAY
54
7
NFLX
57
4
EXPD
29
2
MNST
44
2
ETN
80
2
KEY
68
3
ICE
53
4
AN
43
-6
ROST
55
3
Financhill
Back

Bolt Biotherapeutics Stock Predictions

This Tech Company Grew 32,481%...

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
26

BOLT
Bolt Biotherapeutics

Last Price:
$5.80
Seasonality Move:
-23.31%

7 Day Trial

ALL ACCESS PASS

$ 7

Bolt Biotherapeutics Stock Forecast

  • Over the next 52 weeks, Bolt Biotherapeutics has on average historically fallen by 57.5% based on the past 4 years of stock performance.
  • Bolt Biotherapeutics has fallen lower in 4 of those 4 years over the subsequent 52-week period, corresponding to a historical accuracy of 100%
  • Is Bolt Biotherapeutics Stock Undervalued?
    The current Bolt Biotherapeutics [BOLT] share price is $5.74. The Score for BOLT is 26, which is 48% below its historic median score of 50, and infers higher risk than normal.
  • BOLT is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.

Will Bolt Biotherapeutics Stock Go Up Next Year?

  • Over the next 52 weeks, Bolt Biotherapeutics has on average historically fallen by 57.5% based on the past 4 years of stock performance.

Bolt Biotherapeutics Stock Rating

Sell
26
Bolt Biotherapeutics (BOLT) is a Sell

Is Bolt Biotherapeutics overpriced?

  • Bolt Biotherapeutics has fallen lower in 4 of those 4 years over the subsequent 52-week period, corresponding to a historical accuracy of 100%

Bolt Biotherapeutics Stock Price History

Is BOLT stock going to rise?

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BOLT is experiencing selling pressure, which indicates risk of future bearish movement.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
boltbio.com

52-Week Data

52-Week High:
15.60
52-Week Low:
5.20

Prediction Charts

Market Cap:
11M
Price in USD:
5.74
Volume:
3.3K
Beta:
0.91

Technical Analysis

SMA50:
6.21
SMA100:
7.08
SMA200:
9.29
52-Wk Change:
-61.2%

Stock Predictions

  • Is Bolt Biotherapeutics stock public?
    Yes, Bolt Biotherapeutics is a publicly traded company.
  • What is the Bolt Biotherapeutics stock quote today?
    The Bolt Biotherapeutics stock price is 5.74 USD today.
  • How to buy Bolt Biotherapeutics stock online?
    You can buy Bolt Biotherapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Jun-27 5.88 5.61 5.88 5.52
Jun-30 5.61 5.77 5.87 5.55
Jul-1 5.71 6.00 6.21 5.71
Jul-2 5.92 5.91 6.09 5.86
Jul-3 5.91 5.92 6.04 5.91
Jul-7 5.86 5.87 6.00 5.68
Jul-8 5.79 6.04 6.22 5.79
Jul-9 6.09 6.22 6.30 6.09
Jul-10 6.20 6.32 6.40 6.15
Jul-11 6.15 6.19 6.24 6.04
Jul-14 6.06 5.96 6.16 5.65
Jul-15 5.85 5.65 6.03 5.65
Jul-16 5.68 5.74 5.87 5.62
Jul-17 5.82 5.74 5.87 5.70

Bolt Biotherapeutics Earnings

Bolt Biotherapeutics Earnings Report: Per Share Bolt Biotherapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.

Bolt Biotherapeutics Forecast Revenue Growth

Bolt Biotherapeutics Stock Analysis: Historical quarterly revenues per share for Bolt Biotherapeutics and historical quarterly revenue growth:

  • Analysts estimate an earnings increase this quarter of $1.77 per share, a decrease next quarter of $0.00 per share, an increase this year of $5.93 per share, and a decrease next year of $0.73 per share.

* Bolt Biotherapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.